77 related articles for article (PubMed ID: 6977593)
1. Cell-mediated hyperacute rejection. IV. Lyt markers and adoptive transfer.
Eichwald EJ; Jorgensen C; Graves G
J Immunol; 1982 May; 128(5):2373-4. PubMed ID: 6977593
[No Abstract] [Full Text] [Related]
2. Cell-mediated hyperacute rejection. VIII. The recipient's role in adoptive transfer.
Eichwald EJ; Bernhard EJ; Jorgensen C
Transplantation; 1985 Feb; 39(2):219-20. PubMed ID: 3871543
[No Abstract] [Full Text] [Related]
3. Lyt-1 cells mediate acute murine experimental allergic encephalomyelitis.
Hauser SL; Weiner HL; Bhan AK; Shapiro ME; Che M; Aldrich WR; Letvin NL
J Immunol; 1984 Nov; 133(5):2288-90. PubMed ID: 6332841
[TBL] [Abstract][Full Text] [Related]
4. Transfer of sensitised Lyt 2+ cells triggers acute rejection of pancreatic islet allografts.
Prowse SJ; Warren HS; Agostino M; Lafferty KJ
Aust J Exp Biol Med Sci; 1983 Apr; 61 (Pt 2)():181-5. PubMed ID: 6411053
[TBL] [Abstract][Full Text] [Related]
5. T cell-mediated immunity in malaria. I. The Ly phenotype of T cells mediating resistance to Plasmodium yoelii.
Jayawardena AN; Murphy DB; Janeway CA; Gershon RK
J Immunol; 1982 Jul; 129(1):377-81. PubMed ID: 6979570
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immunity in experimental murine dermatophytosis. II. Adoptive transfer of immunity to dermatophyte infection by lymphoid cells from donors with acute or chronic infections.
Calderon RA; Hay RJ
Immunology; 1984 Nov; 53(3):465-72. PubMed ID: 6333384
[TBL] [Abstract][Full Text] [Related]
7. Adoptive immunotherapy of established syngeneic solid tumors: role of T lymphoid subpopulations.
Rosenstein M; Eberlein TJ; Rosenberg SA
J Immunol; 1984 Apr; 132(4):2117-22. PubMed ID: 6607955
[TBL] [Abstract][Full Text] [Related]
8. Induced expression of class II major histocompatibility complex antigens on thyroid but not pancreatic islet allografts following transfer of sensitized LYT2+ T cells.
Warren HS; Simeonovic CJ; Allan W; Hume DA
Transplant Proc; 1987 Feb; 19(1 Pt 1):213. PubMed ID: 3152690
[No Abstract] [Full Text] [Related]
9. Suppressor cell activation by anti-thy 1.2 in NZB/WF1 mice.
Klassen LW; Zarate A; Gelfand MC; Steinberg AD
J Immunol; 1977 Dec; 119(6):2067-72. PubMed ID: 334981
[No Abstract] [Full Text] [Related]
10. Cell-mediated hyperacute rejection. VII. Suppression by irradiation.
Eichwald EJ; Jorgensen C
Transplantation; 1984 Aug; 38(2):191-2. PubMed ID: 6380046
[No Abstract] [Full Text] [Related]
11. Cell-mediated hyperacute rejection. V. Cessation of transfer effectiveness.
Eichwald EJ; Jorgensen C
Transplantation; 1984 Jul; 38(1):86-7. PubMed ID: 6234689
[No Abstract] [Full Text] [Related]
12. Cells mediating graft rejection in the mouse. IV. The Ly-5, 6, and 8 effector cell phenotype.
Loveland BE; McKenzie IF
Transplantation; 1982 Apr; 33(4):411-3. PubMed ID: 6978559
[TBL] [Abstract][Full Text] [Related]
13. Transfer of cell-mediated hyperacute rejection reaction. The role of active sensitization.
Emam M; Barstad R; Eichwald EJ
Cell Immunol; 1980 Feb; 49(2):426-31. PubMed ID: 6986205
[No Abstract] [Full Text] [Related]
14. Effect of alloantibodies on corneal allograft survival.
Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
[TBL] [Abstract][Full Text] [Related]
15. Adoptive transfer of double negative T regulatory cells induces B-cell death in vivo and alters rejection pattern of rat-to-mouse heart transplantation.
Ma Y; He KM; Garcia B; Min W; Jevnikar A; Zhang ZX
Xenotransplantation; 2008 Feb; 15(1):56-63. PubMed ID: 18333914
[TBL] [Abstract][Full Text] [Related]
16. Immunological response in the mouse brain: II. Experimental immunotherapy model against transplanted mouse lymphoma in the brain.
Keyaki A; Handa H; Yamashita J; Kuribayashi K; Masuda T
Nihon Geka Hokan; 1988 May; 57(3):202-14. PubMed ID: 3266837
[No Abstract] [Full Text] [Related]
17. Cells mediating graft rejection in the mouse. III. Ly-1+ precursor T cells generate skin graft rejection.
Loveland BE; McKenzie IF
Transplantation; 1982 Apr; 33(4):407-10. PubMed ID: 7041367
[TBL] [Abstract][Full Text] [Related]
18. Effects of anti-L3T4 and anti-Lyt 2 monoclonal antibodies on murine cardiac allograft rejection.
Madsen JC; Wood KJ; Morris PJ
Transplant Proc; 1987 Oct; 19(5):3991-2. PubMed ID: 3313979
[No Abstract] [Full Text] [Related]
19. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
